Quantcast

Latest Peptides Stories

2009-11-25 09:21:00

BASKING RIDGE, N.J., Nov. 25 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD, CEO and President, will be presenting at the Piper Jaffray 21st Annual Health Care Conference at the New York Palace Hotel in New York City. Dr. Mazzo's presentation will be given at 1:10pm (EST) on Tuesday, December 1 and will include an overview of the Company's pipeline with emphasis on...

2009-11-12 08:36:00

BASKING RIDGE, N.J., Nov. 12 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD, CEO and President, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference at the St. Regis Hotel in New York City. Dr. Mazzo's presentation will be given at 1:10pm (EST) on Tuesday, November 17 and will include an overview of the Company's pipeline with emphasis on...

2009-11-11 08:15:00

SAN MARCOS, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Natural Alternatives International, Inc. ("NAI")(Nasdaq: NAII), today announced that it has filed a lawsuit in the U.S. District Court for the District of Delaware, accusing Vital Pharmaceutical, Inc. ("VPX") and DNP International Co., Inc. of infringing patents exclusively licensed to NAI relating to its CarnoSyn® beta-alanine. NAI has also asserted claims for unfair competition and false marking against one or both...

2009-11-11 08:00:00

BASKING RIDGE, N.J., Nov. 11 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Chris Rusconi, PhD, Senior Vice President and Chief Scientific Officer, will be presenting an abstract at Biotech 2009 held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Dr. Rusconi's abstract "Aptamer-Active Control Agent Pairs as a Discovery Platform for the Generation of Safer...

2009-11-10 08:00:00

BASKING RIDGE, N.J., Nov. 10 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at Biotech 2009 held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Ms. McDonald's presentation will be given at 10:15am (EST) on Monday, November 16 and will include an overview of...

2009-11-03 08:24:00

BASKING RIDGE, N.J., Nov. 3 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the 3rd Annual Canaccord Adams Cardiovascular Conference at the Nikko Hotel in San Francisco, California. Dr. Mazzo's presentation scheduled for Tuesday, November 10, 2009 at 1:30 PM (PST), will include an overview of the...

2009-10-27 09:00:00

NEW YORK, Oct. 27 /PRNewswire/ -- Life Extension® the global authority on nutrition, health and wellness, as well as a provider of scientific information on anti-aging supplements and therapies, has introduced Glutathione, Cysteine & C product formulated with 50 mg of Setria® Glutathione from Kyowa Hakko USA. Glutathione, Cysteine & C is available from Life Extension® in 100 count bottles at...

2009-10-22 08:41:00

BASKING RIDGE, N.J., Oct. 22 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at the BIO Investor Forum at the Palace Hotel in San Francisco, California at 2:00 PM (PDT) on Thursday, October 29, 2009. Ms. McDonald's presentation will include an overview of the Company's pipeline with emphasis on...

2009-10-20 09:30:00

NEW YORK, Oct. 20 /PRNewswire/ -- Code Blue, billed as the world's first complete recovery drink designed to help the body combat dehydration, replenish vital nutrients, remove harmful toxins and reduce inflammation, has been introduced using Sustamine(TM), L-Alanyl-L-Glutamine from Kyowa Hakko USA in the formulation. Designed by beverage scientists to revive the body, the all natural powerful ingredients in Code Blue allow you to feel better faster by helping the body combat...

2009-10-07 17:29:00

BOULDER, Colo., Oct. 7 /PRNewswire/ -- Waleed Danho, Ph.D., Distinguished Research Leader at Roche was honored last week as the 2009 recipient of the Meienhofer Award for excellence in peptide chemistry at the international peptide symposium, RCCPS (http://www.rochecolorado.com/PeptideSymp09/). Hosted by Roche Colorado, the company's peptide manufacturing facility in Boulder, RCCPS is the only global conference exclusively dedicated to peptides. For Danho, who has a world-wide reputation...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related